在性结肠炎中血清酸酸酶的增加

Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.

Alimentary pharmacology & therapeutics·2011

Fluorescence lifetime system for microscopy and multiwell plate imaging with a blue picosecond diode laser.

Optics letters·2007

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

Alimentary pharmacology & therapeutics·2007

One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.

Alimentary pharmacology & therapeutics·2007

Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.

Alimentary pharmacology & therapeutics·2005

A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.

Alimentary pharmacology & therapeutics·2005

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Rap1b Activates Endosomal AC9 to Drive the Second cAMP Wave.

bioRxiv : the preprint server for biology·2026

Observations of Exocomets.

Space science reviews·2026

Amyloidogenic pituitary prolactinoma.

Indian journal of pathology & microbiology·2026

Investigating Renin-Angiotensin-Aldosterone System Activation in Proliferative Vitreoretinopathy: Elevated Vitreous Angiotensin-Converting Enzyme Levels in Advanced Retinal Detachment.

Current eye research·2026

Endohedral [Au@In10]9- Cluster: Synthesis and Characterization of Na3+xA6-xIn10Au (x = 0, 0.25; A = Rb, Cs).

Inorganic chemistry·2026

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

相关实验视频

在性结肠炎中血清酸酸酶的增加

相关概念视频

Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.

Fluorescence lifetime system for microscopy and multiwell plate imaging with a blue picosecond diode laser.

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.

Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.

A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Rap1b Activates Endosomal AC9 to Drive the Second cAMP Wave.

Observations of Exocomets.

Amyloidogenic pituitary prolactinoma.

Investigating Renin-Angiotensin-Aldosterone System Activation in Proliferative Vitreoretinopathy: Elevated Vitreous Angiotensin-Converting Enzyme Levels in Advanced Retinal Detachment.

Endohedral [Au@In<sub>10</sub>]<sup>9-</sup> Cluster: Synthesis and Characterization of Na<sub>3+<i>x</i></sub><i>A</i><sub>6-<i>x</i></sub>In<sub>10</sub>Au (<i>x</i> = 0, 0.25; <i>A</i> = Rb, Cs).

Basic Science and Pathogenesis.

相关实验视频

在性结肠炎中血清酸酸酶的增加

相关概念视频

相关文章